RH
NYSE:RH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RH
NYSE:RH
|
US |
|
Fiera Milano SpA
MIL:FM
|
IT |
|
E
|
Euro Creations PCL
SET:EURO
|
TH |
|
Arhaus Inc
NASDAQ:ARHS
|
US |
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
CN |
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
KR |
|
A
|
Anglo-Eastern Plantations PLC
LSE:AEP
|
UK |
|
Sekisui House Reit Inc
TSE:3309
|
JP |
|
N
|
Nomura Real Estate Master Fund Inc
TSE:3462
|
JP |
|
I
|
Innovative Medical Management Co Ltd
SZSE:002173
|
CN |
Wall Street
Price Targets
RH Price Targets Summary
RH
According to Wall Street analysts, the average 1-year price target for
RH
is 211.4 USD
with a low forecast of 131.3 USD and a high forecast of 297.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RH's stock price target?
Price Target
211.4
USD
According to Wall Street analysts, the average 1-year price target for
RH
is 211.4 USD
with a low forecast of 131.3 USD and a high forecast of 297.15 USD.
What is RH's Revenue forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
RH's revenue is
10%.
The projected
CAGR
for the next 4 years is
10%.
What is RH's Operating Income forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
RH's operating income is
21%.
The projected
CAGR
for the next 4 years is
22%.
What is RH's Net Income forecast?
Projected CAGR
53%
For the last 13 years the
compound annual growth rate for
RH's net income is
10%.
The projected
CAGR
for the next 4 years is
53%.
